Changes in pial arteriolar diameter and CSF adenosine concentrations during hypoxia

Area of Science:

• Neuroscience
• Pharmacology
• Physiology

Background:

• Cerebral blood flow regulation is crucial for brain function.
• Adenosine is a potential mediator of cerebral blood flow.
• The role of adenosine in hypoxic vasodilation requires further investigation.

Purpose of the Study:

• To investigate the effects of dipyridamole and EHNA on pial arteriolar diameter during hypoxia.
• To measure CSF concentrations of adenosine, inosine, and hypoxanthine under hypoxic conditions.
• To determine the role of adenosine in mediating hypoxic vasodilation.

Main Methods:

• Experiments were conducted on adult male Sprague-Dawley rats under halothane anesthesia.
• Pial arteriolar diameter was observed using closed cranial windows.
• Cerebrospinal fluid (CSF) was collected for analysis of adenosine, inosine, and hypoxanthine.
• Drugs including dipyridamole, EHNA, and theophylline were administered topically or intraperitoneally.
• Hypoxia was induced to observe changes in pial circulation and metabolite concentrations.

Main Results:

• Dipyridamole and EHNA slightly increased resting pial arteriolar diameter.
• Hypoxia caused significant pial arteriolar vasodilation.
• Dipyridamole and EHNA significantly potentiated hypoxic vasodilation.
• Theophylline, an adenosine receptor antagonist, abolished the potentiating effects.
• Hypoxia did not alter CSF nucleobase levels without drug treatment.
• Dipyridamole and EHNA increased CSF adenosine concentrations during hypoxia.

Conclusions:

• Dipyridamole and EHNA enhance hypoxic vasodilation of pial arterioles.
• These drugs increase extracellular adenosine levels during hypoxia.
• The findings support the hypothesis that adenosine plays a key role in regulating cerebral blood flow.
• Adenosine is implicated in the cerebrovascular response to hypoxia.